Sino-Argi Leading Biosciences (603970) — Net Asset Quality Index
Sino-Argi Leading Biosciences (603970) has a Net Asset Quality Index of 27.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥6.57 Billion minus total liabilities of CN¥4.78 Billion yields net assets of CN¥1.78 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Sino-Argi Leading Biosciences (603970) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sino-Argi Leading Biosciences Net Asset Quality Index Over Time (2012–2025)
This chart shows how Sino-Argi Leading Biosciences's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 27.1%, representing net assets of CN¥1.78 Billion against total assets of CN¥6.57 Billion CNY. See Sino-Argi Leading Biosciences (603970) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Sino-Argi Leading Biosciences (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Sino-Argi Leading Biosciences from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Sino-Argi Leading Biosciences market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 35.2% | CN¥1.73 Billion | CN¥4.91 Billion | CN¥3.18 Billion | ▲ +5.2 pp |
| 2024 | 30.0% | CN¥1.68 Billion | CN¥5.60 Billion | CN¥3.92 Billion | ▲ +3.5 pp |
| 2023 | 26.5% | CN¥1.59 Billion | CN¥6.01 Billion | CN¥4.41 Billion | ▲ +2.8 pp |
| 2022 | 23.8% | CN¥1.48 Billion | CN¥6.24 Billion | CN¥4.76 Billion | ▼ -3.2 pp |
| 2021 | 27.0% | CN¥1.28 Billion | CN¥4.74 Billion | CN¥3.46 Billion | ▼ -1.4 pp |
| 2020 | 28.4% | CN¥1.14 Billion | CN¥4.02 Billion | CN¥2.88 Billion | ▼ -9.7 pp |
| 2019 | 38.1% | CN¥1.04 Billion | CN¥2.74 Billion | CN¥1.69 Billion | ▲ +1.1 pp |
| 2018 | 37.0% | CN¥957.07 Million | CN¥2.58 Billion | CN¥1.63 Billion | ▲ +5.9 pp |
| 2017 | 31.1% | CN¥866.35 Million | CN¥2.78 Billion | CN¥1.92 Billion | ▲ +14.4 pp |
| 2016 | 16.7% | CN¥431.42 Million | CN¥2.58 Billion | CN¥2.15 Billion | ▲ +3.0 pp |
| 2015 | 13.7% | CN¥344.56 Million | CN¥2.52 Billion | CN¥2.17 Billion | ▼ -1.1 pp |
| 2014 | 14.8% | CN¥290.44 Million | CN¥1.96 Billion | CN¥1.67 Billion | ▼ -1.1 pp |
| 2013 | 15.9% | CN¥262.68 Million | CN¥1.65 Billion | CN¥1.39 Billion | ▼ -3.7 pp |
| 2012 | 19.6% | CN¥241.63 Million | CN¥1.23 Billion | CN¥991.46 Million | — |